Evidence map›Paper›PMID 31080358›Full record

ArticleMediators of inflammation2019

Epigenetic Regulation of IL-17-Induced Chemokines in Lung Epithelial Cells.

Jiadi Luo, Xiaojing An, Yong Yao, Carla Erb, Annabel Ferguson, Jay K Kolls, Songqing Fan, Kong Chen

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Epigenetic regulation and chromatin organization in cystic fibrosis airways.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Asthma-associated bacterial infections: Are they protective or deleterious?The journal of allergy and clinical immunology. Global · 2023
    Review
  7. Dynamic Changes of NCRInflammation · 2022
    Article
  8. Article
  9. Article
  10. Role of Epigenetics in the Regulation of Immune Functions of the Skin.The Journal of investigative dermatology · 2021
    Review
  11. Article
  12. Regulation of Immune Responses by Nonhematopoietic Cells in Asthma.Journal of immunology (Baltimore, Md. : 1950) · 2021
    Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jiadi LuoDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0003-2060-391X
Xiaojing AnDivision of Pulmonary Medicine, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Yong YaoDivision of Pulmonary Medicine, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Carla ErbDivision of Pulmonary Medicine, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Annabel FergusonDivision of Pulmonary Medicine, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Jay K KollsDepartment of Medicine, Tulane School of Medicine, New Orleans, LA, USA.
Songqing FanDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Kong ChenDivision of Pulmonary Medicine, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.ORCID 0000-0001-6980-5454
University of Pittsburgh Medical Center · USCentral South University · CNTulane University · US

Funding

Training in CD4 T-cell Lung ImmunityR35HL139930 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI KOLLS, JAY K · 2018 to 2024
$6.3M
Epigenetic regulation of chemokines in lung inflammationR01HL137709 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHEN, KONG · 2018 to 2021
$1.6M
NHLBI NIH HHS R01 HL137709NHLBI NIH HHS R35 HL139930
6 · The paper itself

Abstract

Epithelial cells are known to have barrier functions in multiple organs and regulate innate immune responses. Airway epithelial cells respond to IL-17 by altering their transcriptional profiles and producing antimicrobial proteins and neutrophil chemoattractants. Although IL-17 has been shown to promote inflammation through stabilizing mRNA of CXCR2 ligands, how IL-17 exerts its downstream effects on its target cells through epigenetic mechanisms is largely unknown. Using primary human bronchial epithelial cells and immortalized epithelial cell line from both human and mouse, we demonstrated that IL-17-induced CXCR2 ligand production is dependent on histone acetylation specifically through repressing HDAC5. Furthermore, the chemokine production induced by IL-17 is strictly dependent on the bromodomain and extraterminal domain (BET) family as BET inhibition abolished the IL-17A-induced proinflammatory chemokine production, indicating a pivotal role of the recognition of acetylated histones. In combination with single-cell RNA-seq analysis, we revealed that the cell lines we employed represent specific lineages and their IL-17 responses were regulated differently by the DNA methylation mechanisms. Taken together, our data strongly support that IL-17 sustains epithelial CXCR2 ligand production through epigenetic regulation and the therapeutic potential of interrupting histone modification as well as the recognition of modified histones could be evaluated in neutrophilic lung diseases.

Indexed as

AnimalsBlotting, WesternCell LineCells, CulturedChemokinesEpigenesis, GeneticEpithelial CellsHistone DeacetylasesHumansInterleukin-17LungMiceReal-Time Polymerase Chain ReactionChemokinesHistone DeacetylasesInterleukin-17

Identifiers

PMID31080358
PMCPMC6441531
OpenAlexW2922046965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.